Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Shares Outstanding (Entity) (2012 - 2026)

Updated

Grace Therapeutics (GRCE) reported Shares Outstanding (Entity) of 20.12 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 42.4% from 14.13 million a year earlier and up 23.6% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Grace Therapeutics posted Shares Outstanding (Entity) of 16.02 million, up 16.8% from FY2025.

  • Shares Outstanding (Entity) has increased for eight consecutive fiscal years, with a five-year compound annual growth rate of 45.3% (FY2021 to FY2026).
  • By fiscal year, Shares Outstanding (Entity) came in at 13.72 million in FY2025 (+45.9%), 9.4 million in FY2024 (+26.4%), 7.44 million in FY2023 (+21.1%) and 6.14 million in FY2022 (+148.5%).
  • The fiscal Q2 2027 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q4 2012.
  • Year over year, Shares Outstanding (Entity) has now increased in each of the last 27 quarters, with growth averaging 32.4% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.3% (fiscal Q1 2024) and 220.7% (fiscal Q3 2022) over the last five years.
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at 16.27 million (Q1 2027), 16.02 million (Q4 2026) and 15.47 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 940.75 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 2.41 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 1.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 540.90 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.24 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.70 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 21.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20.12 Mn
Jun 30, 2026 16.27 Mn
Mar 31, 2026 16.02 Mn
Dec 31, 2025 15.47 Mn
Sep 30, 2025 14.13 Mn
Jun 30, 2025 13.83 Mn
Mar 31, 2025 13.72 Mn
Dec 31, 2024 10.14 Mn
Sep 30, 2024 10.14 Mn
Jun 30, 2024 10.14 Mn
Mar 31, 2024 9.40 Mn
Dec 31, 2023 9.40 Mn
Sep 30, 2023 7.55 Mn
Jun 30, 2023 7.44 Mn
Mar 31, 2023 7.44 Mn
Dec 31, 2022 7.44 Mn
Sep 30, 2022 7.44 Mn
Jun 30, 2022 7.42 Mn
Mar 31, 2022 6.14 Mn
Dec 31, 2021 7.38 Mn
API Access

Grace Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GRCE&period=max&api_key=YOUR_API_KEY